Bone Marrow TransplantationTransplantation, AutologousBone MarrowBone Marrow CellsHematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationStem CellsGraft vs Host DiseaseHematopoietic Stem CellsTransplantation ConditioningWhole-Body IrradiationCombined Modality TherapyMelphalanMultiple MyelomaBone Marrow PurgingCyclophosphamideRemission InductionAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeBone and BonesPeripheral Blood Stem Cell TransplantationBusulfanRecurrenceGraft SurvivalAnemia, AplasticLymphoma, Non-HodgkinLeukemiaTransplantation ChimeraEtoposideSalvage TherapyCarmustineHodgkin DiseaseDisease-Free SurvivalHematopoietic Stem Cell MobilizationHematopoiesisCytarabineTissue DonorsLiver TransplantationBone Marrow DiseasesThiotepaHistocompatibility TestingSurvival AnalysisSurvival RateTime FactorsCell DifferentiationHistocompatibilityLeukemia, Myeloid, AcuteVincristineHematologic NeoplasmsMice, Inbred C57BLRetrospective StudiesAntigens, CD34Transplantation, IsogeneicBone Marrow ExaminationAdult Stem CellsGranulocyte Colony-Stimulating FactorLeukemia, MyeloidMesenchymal Stem Cell TransplantationRadiation ChimeraMyeloablative AgonistsBone Marrow NeoplasmsFollow-Up StudiesColony-Forming Units AssayLeukemia, Myelogenous, Chronic, BCR-ABL PositiveKidney TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaCells, CulturedImmunosuppressive AgentsPrognosisLymphomaMyelodysplastic SyndromesAcute DiseaseT-LymphocytesEmbryonic Stem CellsFlow CytometryMesenchymal Stromal CellsGraft RejectionHepatic Veno-Occlusive DiseasePluripotent Stem CellsAmyloidosisDexamethasoneDoxorubicinStem Cell NicheTransplantation ImmunologyLymphoma, FollicularPodophyllotoxinBone RemodelingImmunosuppressionLymphocyte DepletionChimeraGraft vs Host ReactionPrednisoneLymphoma, Mantle-CellCell LineageBoronic AcidsLeukocyte TransfusionCell SeparationNeoplasm, ResidualPyrazines